Online inquiry

Surface Charge Characterization Service

Introduction Surface Charge Characterization Workflow What We Can Offer FAQs

Introduction

Nucleic acid delivery's molecular pharmacology depends on nanocarrier surface properties. Zeta Potential defines colloidal stability and membrane interaction. Creative Biolabs' service offers precise measurement/kinetic analysis to optimize these parameters, backed by LNP-protein interaction literature.

Creative Biolabs provides a Custom Surface Charge Characterization Service. It optimizes stability/uptake via advanced Zeta Potential and binding analysis, delivers high-resolution data for formulation integrity and in vivo prediction, and defines nanocarrier physicochemical traits to meet stability/biological interaction criteria.

Discover How We Can Help - Request a Consultation

Surface Charge Characterization Service

Core Detection Indicators

Zeta Potential (ZP) A key indicator for measuring the electrokinetic potential on the particle surface. It directly reflects the strength of electrostatic repulsion between particles and serves as a core parameter for judging LNP colloidal stability.
Surface Charge Density The amount of charge carried per unit area on the LNP surface. It quantifies the "density" of surface charge, and more intuitively reflects charge-carrying capacity compared to zeta potential.
Isoelectric Point (pI) The pH value of the solution at which the net charge on the LNP surface is zero. It determines the charge state of LNPs in environments with different pH values, and is crucial for formulation pH optimization and in vivo targeting design.
Surface Charge Uniformity Evaluates the degree of difference in surface charge among particles in an LNP population. Uneven charge distribution increases the risk of particle aggregation and affects formulation stability.

Corresponding Detection Methods

  • Laser Doppler Electrophoresis (LDE): Uses an electric field to drive LNP electrophoresis, the laser Doppler effect to measure migration rate, and the Henry equation to calculate zeta potential. Simple, small sample volume (10-100μL), fast, routine method for zeta potential and isoelectric point.
  • Potentiometric Titration: Adds acid/alkali/electrolyte dropwise, monitors pH and potential changes to calculate surface charge density and isoelectric point. Directly quantifies charge density; the titration curve shows the charge-pH relation clearly.
  • Resonant Mirror Method: Uses a sensor to measure LNP adsorption rate on charged surfaces, inferring charge properties and uniformity indirectly. No labeling, near-physiological analysis, sensitive to charge distribution, for charge uniformity, and relative intensity.
  • Streaming Potential Method: Forces LNP suspension through porous membrane, measures streaming potential to calculate surface charge density. Suitable for high concentrations, simulates a real storage environment, for charge density and colloidal stability correlation.

Workflow

Our workflow is designed for transparency and efficiency, ensuring every client understands the rigorous process involved in characterizing their unique formulation.

Required Starting Materials

  • Purified nanocarrier sample (defined concentration, buffer).
  • Formulation blueprint (lipid/polymer ratios, identities).
  • Target environment specs (pH, buffer salts, media).
Consultation & Design
Sequence Optimization

Initial Sample Assessment

Check quality (e.g., DLS size) to qualify the sample, define parameters.

Electrophoretic Mobility Measurement

Use LDA to measure particle movement; get raw data.

Chemical Modifications
Synthesis & Purification

Zeta Potential Calculation

Apply the equation to get ZP value (mV); core electrostatic measure.

Stability Testing (Titration)

Map stability via ZP across pH/ionic strengths; find optimal window.

Quality Control & Validation
Delivery & Support

Optional Binding Kinetics

Use SPR to get KD, ka, and kd for biodistribution prediction.

Final Deliverables

  • Comprehensive CQA Report: ZP values (mV) + standard deviation.
  • Stability Profile Mapping: Charts of stability vs. environmental variables.
  • Raw Data and Method Protocol: Full parameters, raw mobility files.
  • Estimated Timeframe: 3–6 weeks for standard ZP projects; varies by formulation complexity, SPR inclusion.
Consultation & Design

What We Can Offer

As leading experts in nanomedicine surface science, Creative Biolabs offers a dedicated, consultative service model built around your specific therapeutic goals. We don't just provide data; we provide customized, regulatory-ready surface intelligence to propel your drug development forward.

Customized Environment Mimicry
Analytical protocols are meticulously tailored (e.g., buffer pH, osmolarity, specific serum protein spiking) to precisely reflect the target delivery tissue or final drug product storage conditions.

Multimodal Surface Intelligence
Comprehensive, one-stop characterization combining static charge (Zeta Potential) and dynamic interaction (SPR kinetics) for the most complete predictive surface profile.

Regulatory-Centric Quality System
Our entire workflow adheres to Quality-by-Design (QbD) principles, ensuring all data generated is high-integrity, traceable, and suitable for direct inclusion in regulatory filings.

Adaptability Across Nanocarriers
Proven capability to accurately characterize diverse cationic delivery systems, including lipid nanoparticles, polyplexes, and liposomes, across various nucleic acid payloads (mRNA, siRNA, oligonucleotide).

Predictive Species Cross-Reactivity
Custom binding screens against ApoE homologs from human, rodent, and primate sources to de-risk preclinical translation by validating your chosen animal model in vitro.

Experience the Creative Biolabs Advantage - Get a Quote Today

Case Study

To evaluate the average hydrodynamic diameters of two LNP preparations before and after encapsulating RNA cargo, and the Zeta potential measurements before and after encapsulating RNA cargo at three different pH values.

The average hydrodynamic diameters of two LNP preparations, MC3-LNP and SM102-LNP, before and after encapsulating RNA cargo, and the measured Zeta potential values of them before and after encapsulating RNA cargo at three different pH values. (OA Literature)Fig.1 Formulation and characteristic detection of LNP.1

Customer Reviews

  • Exceptional Stability Data: "Using Creative Biolabs' Custom Surface Charge Characterization Service in our research significantly deepened our understanding of LNP shelf-life. The detailed titration curves across various ionic strengths helped us define a stable storage buffer formulation, completely resolving the batch aggregation issues we previously faced. The data quality was excellent."

    — Dr. Jennifer Harris (2025)

  • Accurate Biodistribution Prediction: "The Surface Plasmon Resonance (SPR)-based kinetic data provided by Creative Biolabs for our new immunomodulatory nanocarrier was invaluable. We compared our formulation's Apolipoprotein E (ApoE) affinity across multiple species, and the results perfectly aligned with our subsequent Pharmacokinetic (PK) study, validating the effectiveness of our preclinical model. This saved us months of wasted effort."

    — Dr. Adam Martin (2025)

  • Critical CQA Benchmark: "Creative Biolabs provided clear, quantitative benchmark data for our LNP production. Their Zeta Potential report helped us identify a slight deviation in our large-scale synthesis process—this deviation was impacting encapsulation efficiency. We were able to adjust the flow parameters immediately, ensuring the Critical Quality Attribute (CQA) specifications of our Phase II clinical trial materials remained within the required limits."

    — Dr. Thomas Scott (2025)

FAQs

Why is Zeta Potential measurement necessary if my LNPs already show high encapsulation efficiency?

Encapsulation efficiency only tells you how much payload is inside; Zeta Potential measures the outer surface charge, which governs the particle's stability in solution and its ability to enter the cell. A high-encapsulation LNP with a poor Zeta Potential will aggregate quickly or be rejected by the cell membrane, making the payload effectively useless in vivo. We help you optimize both.

Can your service help me predict if my LNP will target the liver or another organ?

Yes. While final organ tropism is complex, the Biomolecular Corona is the key determinant. We use SPR binding assays to measure the affinity of your LNP for crucial serum proteins like ApoE. High ApoE affinity is a strong predictor of liver (hepatic) targeting via the LDLR pathway, giving you a powerful, early-stage predictive tool.

What is the most common precaution I should be aware of when interpreting Zeta Potential data?

The most critical precaution is the dependency on the medium. The Zeta Potential value will change drastically based on the pH and salt concentration of the buffer. Our reports are specific, and we recommend always using a buffer that closely simulates your target physiological or storage condition for meaningful data interpretation.

How does SPR characterization compare to traditional stability assays like DLS?

DLS (Dynamic Light Scattering) measures particle size and distribution (polydispersity), which is an indirect measure of stability. SPR is fundamentally different: it is a direct, kinetic measurement of biomolecular interaction. It tells you how strongly your LNP binds to a target protein, which DLS cannot do. Using both provides a complete picture of your formulation's quality.

My current LNP formulation is highly cationic. Does your service offer any guidance on reducing positive charge while maintaining efficacy?

Absolutely. Highly positive LNPs can sometimes lead to increased systemic toxicity or non-specific binding. Our characterization workflow, particularly the pH titration aspect, helps identify the optimal formulation ratio that yields a near-neutral charge in circulation but still possesses the optimal pKa for triggered endosomal release, helping you balance efficacy and tolerability.

Creative Biolabs' analytical intelligence is required to develop stable, targeted, and highly efficacious mRNA nanotherapeutics. By combining gold-standard Zeta Potential measurement for stability assurance with advanced SPR binding kinetics for biodistribution prediction, we furnish your project with the quantitative data required for confident progression toward the clinic.

Contact Our Team for More Information and to Discuss Your Project

Reference

  1. Lew, Benjamin, et al. "Surface Plasmon Resonance Based Binding Characterization for Screening RNA-Loaded Lipid Nanoparticles (LNPs): Exploring Species Cross-Reactivity in LNP–Apolipoprotein E Interactions." Molecular Pharmaceutics 22.8 (2025): 4587-4596. https://doi.org/10.1021/acs.molpharmaceut.5c00068. Distributed under Open Access license CC BY 4.0, without modification.
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.